| 图片 | 名称及描述 | |
|---|---|---|
|
α-L-Talofuranuronamide, 5-O-[N-[2-(1-cyclohexen-1-yl)ethyl]-4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[N-(cyclohexylmethyl)-4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[2,3-bis-O-(11-aminoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[N-[(1S)-1-carboxy-3-butenyl]-4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[N-(3-aminophenyl)-4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[N-(4-decylphenyl)-4-deoxy-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronamide, 5-O-[3-O-[(decyloxy)carbonyl]-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
|
||
|
α-L-Talofuranuronic acid, 2,3-O-cyclohexylidene-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-[methyl[1-oxo-3-phenyl-2-[[(phenylmethoxy)carbonyl]amino]propyl]amino]-, (S)- (9CI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranoguanosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranoguanosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranoguanosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranoadenosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranoadenosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|
||
|
α-L-talo-Heptofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-7′)-6′-deoxy-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)
97%
|

